These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36672730)

  • 1. Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine.
    Volnova A; Kurzina N; Belskaya A; Gromova A; Pelevin A; Ptukha M; Fesenko Z; Ignashchenkova A; Gainetdinov RR
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats
    Kurzina N; Belskaya A; Gromova A; Ignashchenkova A; Gainetdinov RR; Volnova A
    Front Psychiatry; 2022; 13():851296. PubMed ID: 35401264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats.
    Ptukha M; Fesenko Z; Belskaya A; Gromova A; Pelevin A; Kurzina N; Gainetdinov RR; Volnova A
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rats Lacking the Dopamine Transporter Display Inflexibility in Innate and Learned Behavior.
    Belskaya A; Kurzina N; Savchenko A; Sukhanov I; Gromova A; Gainetdinov RR; Volnova A
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.
    Leo D; Sukhanov I; Zoratto F; Illiano P; Caffino L; Sanna F; Messa G; Emanuele M; Esposito A; Dorofeikova M; Budygin EA; Mus L; Efimova EV; Niello M; Espinoza S; Sotnikova TD; Hoener MC; Laviola G; Fumagalli F; Adriani W; Gainetdinov RR
    J Neurosci; 2018 Feb; 38(8):1959-1972. PubMed ID: 29348190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Paradigm for Training Hyperactive Dopamine Transporter Knockout Rats: Influence of Novel Stimuli on Object Recognition.
    Kurzina NP; Volnova AB; Aristova IY; Gainetdinov RR
    Front Behav Neurosci; 2021; 15():654469. PubMed ID: 33967714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological and Behavioral Markers of Hyperdopaminergia in DAT-KO Rats.
    Fesenko Z; Ptukha M; da Silva MM; de Carvalho RSM; Tsytsarev V; Gainetdinov RR; Faber J; Volnova AB
    Biomedicines; 2024 Sep; 12(9):. PubMed ID: 39335627
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions.
    Fukuyama K; Nakano T; Shiroyama T; Okada M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze.
    Kurzina NP; Aristova IY; Volnova AB; Gainetdinov RR
    Behav Brain Res; 2020 Jul; 390():112642. PubMed ID: 32428629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for cortical dopamine in the paradoxical calming effects of psychostimulants.
    Harris SS; Green SM; Kumar M; Urs NM
    Sci Rep; 2022 Feb; 12(1):3129. PubMed ID: 35210489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2006 Dec; 2():41. PubMed ID: 17173664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
    Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids/glucocorticoid receptors effect on dopaminergic neurotransmitters in ADHD rats.
    Chen Y; Zheng X; Xie L; Huang L; Ke Z; Zheng J; Lu H; Hu J
    Brain Res Bull; 2017 May; 131():214-220. PubMed ID: 28458039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
    Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
    Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex.
    Okada M; Fukuyama K; Kawano Y; Shiroyama T; Suzuki D; Ueda Y
    Neuropharmacology; 2019 Sep; 156():107547. PubMed ID: 30802458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system.
    Adinolfi A; Zelli S; Leo D; Carbone C; Mus L; Illiano P; Alleva E; Gainetdinov RR; Adriani W
    Behav Brain Res; 2019 Feb; 359():516-527. PubMed ID: 30472113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cliff avoidance reaction in dopamine transporter knockout mice.
    Yamashita M; Sakakibara Y; Hall FS; Numachi Y; Yoshida S; Kobayashi H; Uchiumi O; Uhl GR; Kasahara Y; Sora I
    Psychopharmacology (Berl); 2013 Jun; 227(4):741-9. PubMed ID: 23397052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
    Yamashita M; Fukushima S; Shen HW; Hall FS; Uhl GR; Numachi Y; Kobayashi H; Sora I
    Neuropsychopharmacology; 2006 Oct; 31(10):2132-9. PubMed ID: 16407898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine.
    Franowicz JS; Kessler LE; Borja CM; Kobilka BK; Limbird LE; Arnsten AF
    J Neurosci; 2002 Oct; 22(19):8771-7. PubMed ID: 12351753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuronal development of the hyperdopaminergic animal model].
    Kasahara Y; Arime Y; Kubo Y; Fukui A; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):195-9. PubMed ID: 22256607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.